Ontology highlight
ABSTRACT:
We used methylated DNA immunoprecipitation (MeDIP), combined with microarray technology (Keshet et al., 2006; Weber et al., 2005), to discover whether changes in DNA methylation are specific to T2DM. A cohort of normal glucose tolerant (NGT) and Type 2 diabetic (T2DM) male volunteers was studied.
ORGANISM(S): Homo sapiens
DISEASE(S): NGT
SUBMITTER: Romain Barres
PROVIDER: E-MEXP-2253 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
Barrès Romain R Osler Megan E ME Yan Jie J Rune Anna A Fritz Tomas T Caidahl Kenneth K Krook Anna A Zierath Juleen R JR
Cell metabolism 20090901 3
Epigenetic modification through DNA methylation is implicated in metabolic disease. Using whole-genome promoter methylation analysis of skeletal muscle from normal glucose-tolerant and type 2 diabetic subjects, we identified cytosine hypermethylation of peroxisome proliferator-activated receptor gamma (PPARgamma) coactivator-1 alpha (PGC-1alpha) in diabetic subjects. Methylation levels were negatively correlated with PGC-1alpha mRNA and mitochondrial DNA (mtDNA). Bisulfite sequencing revealed th ...[more]